TickerFacts.

GT Biopharma, Inc. (GTBP): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$3.66M
Year ended 2019-12-31
2011-12-31: -$963.0K2012-12-31: -$989.0K2013-12-31: -$442.0K2014-12-31: -$1.75M2015-12-31: -$4.66M2016-12-31: -$1.93M2017-12-31: -$5.43M2018-12-31: -$10.71M2019-12-31: -$3.66M-$3.66M
2011-12-31 Free Cash Flow (USD) 2019-12-31
Period endedFree Cash FlowChange YoYSource filing
2019-12-31-$3.66Mn/m2021-04-16, From 2019-01-01
2018-12-31-$10.71Mn/m2020-03-27, From 2018-01-01
2017-12-31-$5.43Mn/m2019-03-29, From 2017-01-01
2016-12-31-$1.93Mn/m2018-03-01, From 2016-01-01
2015-12-31-$4.66Mn/m2018-02-28, From 2015-01-01
2014-12-31-$1.75Mn/m2018-02-28, From 2014-01-01
2013-12-31-$442.0Kn/m2015-03-31, From 2013-01-01
2012-12-31-$989.0Kn/m2015-01-08, From 2012-01-01
2011-12-31-$963.0Kn/a2014-11-18, From 2011-01-01